Search results
Showing 3451 to 3500 of 3807 results for treatment
Evidence-based recommendations on insertion of customised exposed titanium implants, without soft tissue cover, for complex orofacial reconstruction. This involves making the titanium implants specially to fit the person using a model of their face.
View recommendations for HTG313Show all sections
Sections for HTG313
Lumbar infusion test for the investigation of normal pressure hydrocephalus (HTG169)
Evidence-based recommendations on the lumbar infusion test for the investigation of normal pressure hydrocephalus. This involves inserting a lumbar needle into the spinal sac, recording the pressure of the CSF as fluid is infused into the sac.
View recommendations for HTG169Show all sections
Sections for HTG169
Thoracoscopic repair of congenital diaphragmatic hernia in neonates (HTG247)
Evidence-based recommendations on thoracoscopic repair of congenital diaphragmatic hernia in neonates. This involves inserting surgical instruments through small cuts in the chest, and then moving the abdominal organs out of the chest and repairing the diaphragm.
View recommendations for HTG247Show all sections
Sections for HTG247
Digital technologies to support smoking cessation in secondary care patients: early value assessment
In development Reference number: GID-HTE10061 Expected publication date: TBC
PROPEL sinus implants for maintaining sinus patency after surgery (MIB253)
NICE has developed a medtech innovation briefing (MIB) on PROPEL sinus implants for maintaining sinus patency after surgery .
Sternal Talon for sternal closure in cardiothoracic surgery (MIB88)
NICE has developed a medtech innovation briefing (MIB) on the Sternal Talon for sternal closure in cardiothoracic surgery .
LATITUDE NXT Patient Management System for monitoring cardiac devices at home (MIB67)
NICE has developed a medtech innovation briefing (MIB) on the LATITUDE NXT Patient Management System for monitoring cardiac devices at home
collect clinical data from people treated with the new generation of HCV treatments. NICE agreed that such efforts should be supported...
MRI fusion biopsy systems for diagnosing prostate cancer (HTG678)
Evidence-based recommendations on MRI fusion biopsy systems for diagnosing prostate cancer.
Evidence-based recommendations on Episcissors-60 for mediolateral episiotomy.
Biotin for treating primary and secondary progressive multiple sclerosis [ID919]
Discontinued Reference number: GID-TA10099
symptoms, and other treatments used at the same time. It should also report details of the technique, including dose and number of...
Can vitamin D slow down the progression of disability in Multiple Sclerosis (MS)?
after the onset of relapsing–remitting MS. While a variety of symptomatic treatments is available, progression in secondary progressive...
Placement of pectus bar for pectus excavatum (also known as MIRPE or the Nuss procedure) (HTG199)
Evidence-based recommendations on placement of pectus bar for pectus excavatum (Nuss procedure). This involves placing one or two steel (pectus) bars under the breastbone with the aim of raising it and correcting the abnormal shape.
View recommendations for HTG199Show all sections
Sections for HTG199
Evidence-based recommendations on percutaneous closure of patent foramen ovale for the secondary prevention of recurrent paradoxical embolism in divers. This involves passing a device through a large vessel in the groin up into the heart and closing/blocking the hole in the wall.
View recommendations for HTG243Show all sections
Sections for HTG243
Science policy projects with NICE.
Abrocitinib for treating moderate to severe atopic dermatitis in people aged 12 and over [ID3768]
Discontinued Reference number: GID-TA10764
Vitamin D: supplement use in specific population groups (PH56)
This guideline covers vitamin D supplement use. It aims to prevent vitamin D deficiency among specific population groups including infants and children aged under 4, pregnant and breastfeeding women, particularly teenagers and young women, people over 65, people who have low or no exposure to the sun and people with dark skin.
ViewSite Brain Access System (VBAS) for the surgical management of deep brain lesions (MIB295)
NICE has developed a medtech innovation briefing (MIB) on ViewSite Brain Access System (VBAS) for the surgical management of deep brain lesions .
Evidence-based recommendations on short-term circulatory support with left ventricular assist devices (LVAD) as a bridge to heart transplantation or recovery. This involves inserting a mechanical device into the chest to help the heart pump blood around the body.
View recommendations for HTG115Show all sections
Sections for HTG115
Endoscopic full thickness removal of non-lifting colonic polyps (HTG439)
Evidence-based recommendations on endoscopic full thickness removal of non-lifting colonic polyps. This involves using a special device to remove the polyp and seal the bowel wall closed afterwards.
View recommendations for HTG439Show all sections
A step-by-step summary about how we develop our technology appraisal guidance.
Discontinued Reference number: GID-TAG402
NICE has developed a medtech innovation briefing (MIB) on ReStore Soft Exo-Suit for gait rehabilitation .
COVID-19 rapid guideline: delivery of systemic anticancer treatments (NG161)
September 2023: This guideline has been withdrawn because current practice is to manage COVID-19 risk in line with risk of other respiratory infections. For people with COVID-19 see our guideline on managing COVID-19.
Virtual chromoendoscopy to assess colorectal polyps during colonoscopy (HTG438)
Evidence-based recommendations on virtual chromoendoscopy (VCE) using NBI, FICE or i-scan to assess colorectal polyps of 5 mm or less during colonoscopy.
Discontinued Reference number: GID-TA10739
ClearWay RX for drug delivery to coronary artery thrombotic lesions (MIB55)
NICE has developed a medtech innovation briefing (MIB) on ClearWay RX for drug delivery to coronary artery thrombotic lesions
for oxygen therapy (including thresholds for this decision)• Costs of treatment• Time to recovery• Health-related quality of life•...
Discontinued Reference number: GID-TA11277
This manual explains how NICE develops and updates social care guidance. It provides advice on the technical aspects of guidance development and the methods used
Transperineal biopsy for diagnosing prostate cancer (HTG680)
Evidence-based recommendations on transperineal biopsy for diagnosing prostate cancer.
YOURmeds for medication support in long-term conditions (MIB289)
NICE has developed a medtech innovation briefing (MIB) on YOURmeds for medication support in long-term conditions .
i STAT CG4+ and CHEM8+ cartridges for point-of-care testing in the emergency department (MIB38)
NICE has developed a medtech innovation briefing (MIB) on i STAT CG4+ and CHEM8+ cartridges for point-of-care testing in the emergency department
This guideline covers changing health-damaging behaviours among people aged 16 and over using interventions such as goals and planning, feedback and monitoring, and social support. It aims to help tackle a range of behaviours including alcohol misuse, poor eating patterns, lack of physical activity, unsafe sexual behaviour and smoking.
This guidance has been updated and replaced by NICE technology appraisal guidance 604.
Discontinued Reference number: GID-TA11399
committee's discussion are in evidence review K: cessation and harm-reduction treatments. Source guidance details Comes from guidance...
committee's discussion are in evidence review K: cessation and harm-reduction treatments. Source guidance details Comes from guidance...
evidence and the committee's discussion are in evidence review H: initial treatments for differentiated thyroid cancer. Source guidance...
committee made the recommendation for research, see the rationale section on treatments for moderate and severe OSAHS . Full details of...
committee made the recommendation for research, see the rationale section on treatments for moderate and severe OSAHS. Full details of...
Sophie Cooper, senior scientific adviser in NICE’s science policy team, explains the importance of the recently published EQ-5D-5L value set and how it has the potential to help us decide if new treatments offer good value for money for the NHS.
committee's discussion are in evidence review K: cessation and harm-reduction treatments. Source guidance details Comes from guidance...
committee made the recommendation for research, see the rationale section on treatments for mild OSAHS . Full details of the evidence...
committee's discussion are in evidence review K: cessation and harm-reduction treatments. Source guidance details Comes from guidance...
discussion are in: - evidence review K: cessation and harm-reduction treatments - evidence review M: long-term health effects of...
opioids and compound analgesics) are sometimes used with disease-modifying treatments to relieve pain and stiffness when symptom control...
people with dementia, their families and the NHS, and there is no effective treatment to prevent its progression.Hearing loss is...